SERPINA3, an inhibitor of neutrophil cathepsin G and mast cell chymase that can transform inactive angiotensin-1 into active angiotensin-2, deserves further study in ARDS/ALI associated with both direct and indirect lung injury factors. This evidence concerns the gene AGT and acute respiratory distress syndrome.